Logo image of KDLY

KINDLY MD INC (KDLY) Stock Fundamental Analysis

USA - NASDAQ:KDLY - US49457M1062 - Common Stock

24.94 USD
+2.11 (+9.24%)
Last: 5/22/2025, 8:19:19 PM
23.6 USD
-1.34 (-5.37%)
After Hours: 5/22/2025, 8:19:19 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KDLY. KDLY was compared to 100 industry peers in the Health Care Providers & Services industry. KDLY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KDLY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KDLY has reported negative net income.
KDLY had a negative operating cash flow in the past year.
KDLY Yearly Net Income VS EBIT VS OCF VS FCFKDLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

KDLY has a Return On Assets of -170.60%. This is amonst the worse of the industry: KDLY underperforms 95.15% of its industry peers.
KDLY's Return On Equity of -286.01% is on the low side compared to the rest of the industry. KDLY is outperformed by 79.61% of its industry peers.
Industry RankSector Rank
ROA -170.6%
ROE -286.01%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDLY Yearly ROA, ROE, ROICKDLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

KDLY has a better Gross Margin (96.64%) than 100.00% of its industry peers.
KDLY's Gross Margin has been stable in the last couple of years.
KDLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
KDLY Yearly Profit, Operating, Gross MarginsKDLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

KDLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KDLY has more shares outstanding
KDLY has a better debt/assets ratio than last year.
KDLY Yearly Shares OutstandingKDLY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
KDLY Yearly Total Debt VS Total AssetsKDLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

KDLY has an Altman-Z score of 88.79. This indicates that KDLY is financially healthy and has little risk of bankruptcy at the moment.
KDLY's Altman-Z score of 88.79 is amongst the best of the industry. KDLY outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KDLY is not too dependend on debt financing.
The Debt to Equity ratio of KDLY (0.00) is better than 83.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 88.79
ROIC/WACCN/A
WACC9.04%
KDLY Yearly LT Debt VS Equity VS FCFKDLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 2.30 indicates that KDLY has no problem at all paying its short term obligations.
KDLY has a Current ratio of 2.30. This is amongst the best in the industry. KDLY outperforms 80.58% of its industry peers.
KDLY has a Quick Ratio of 2.30. This indicates that KDLY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KDLY (2.30) is better than 83.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.3
KDLY Yearly Current Assets VS Current LiabilitesKDLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for KDLY have decreased strongly by -156.41% in the last year.
The Revenue for KDLY has decreased by -28.12% in the past year. This is quite bad
KDLY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.79% yearly.
EPS 1Y (TTM)-156.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182%
Revenue 1Y (TTM)-28.12%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-30.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDLY Yearly Revenue VS EstimatesKDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KDLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDLY Price Earnings VS Forward Price EarningsKDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDLY Per share dataKDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KDLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KINDLY MD INC

NASDAQ:KDLY (5/22/2025, 8:19:19 PM)

After market: 23.6 -1.34 (-5.37%)

24.94

+2.11 (+9.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.28%
Inst Owner Change8003.57%
Ins Owners2.41%
Ins Owner Change38.89%
Market Cap168.34M
Revenue(TTM)2.47M
Net Income(TTM)-4.37M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 68.14
P/FCF N/A
P/OCF N/A
P/B 110.09
P/tB 174.04
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.37
BVpS0.23
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -170.6%
ROE -286.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.64%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 435.44%
Cap/Sales 22.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.3
Quick Ratio 2.3
Altman-Z 88.79
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-156.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.12%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-30.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-151.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A

KINDLY MD INC / KDLY FAQ

What is the fundamental rating for KDLY stock?

ChartMill assigns a fundamental rating of 2 / 10 to KDLY.


What is the valuation status for KDLY stock?

ChartMill assigns a valuation rating of 0 / 10 to KINDLY MD INC (KDLY). This can be considered as Overvalued.


Can you provide the profitability details for KINDLY MD INC?

KINDLY MD INC (KDLY) has a profitability rating of 1 / 10.


Can you provide the financial health for KDLY stock?

The financial health rating of KINDLY MD INC (KDLY) is 6 / 10.